Morton’s neuroma (MN) is a common cause of forefoot pain. Four etiopathogenic theories have been proposed: chronic trauma damage, inflammatory environment due to intermetatarsal bursitis, compression by the deep transverse intermetatarsal ligament and ischemia of the vasa nervorum [1]. These processes may be occurring concurrently [2]. The treatment for MN is initially conservative, which includes patients’ education on avoidance of tight shoes, anti-inflammatory drugs or physiotherapy. If it fails, infiltrative therapies should be considered [2-4]. Infiltrative treatments include injection of local anesthetics, steroids or alcohol,...

Population We prospectively studied 12 patients (11 female, 1 male) with symptomatic MN and failure of conservative treatment between May 2018 and June 2019. All subjects were clinically diagnosed by the Foot and Ankle Service and were confirmed by imaging (Ultrasound or MRI). Before the procedure a single, expert, musculoskeletal radiologist evaluated the presence of symptomatic MN and looked for another forefoot pain causes with ultrasound examination. Procedure All patients provided written informed consent. All percutaneous procedures were performed with ultrasound guidance by the same...

On average, the patients were aged 57 years (range 38–72). 9 MN were located on third metatarsal space and 3 on the second. The average diameter of the MN was 10.3 mm (range 10-14). 5 of the patients (45.5 %) presented concomitant metatarsalgia, and 1 of those (0.09 %) also rheumatoid arthritis. 6 of the patients (50%) used anti-inflammatory medication for pain control. On average, patients were followed-up for 95 days (range from 18 to 247). Pre-treatment pain average was 5.3. Post-treatment pain average was...

In this study, we have prospectively investigated the effectiveness and safety of ultrasound-guided radiofrequency of symptomatic Morton’s neuroma in a cohort of 12 patients unresponsive to conservative treatment. We found a positive tendency in pain improvement in most patients, but differences did not reached the level of significance. These results could be partially explained because of the small sample size. Other studies used different scores for assessing effectiveness, like Visual Assesment Score [6, 8]. We decided to use BPI in order to better evaluate the...

F. García Martínez; Madrid/ES - nothing to disclose J. M. López Vega; Madrid/ES - nothing to disclose A. J. Barrios Lopez; Madrid/ES - nothing to disclose E. Lanz Santos; Madrid/ES - nothing to disclose M. Caicoya; Madrid, MADRID/ES - nothing to disclose V. M. M. Muley Luelmo; Madrid/ES - nothing to disclose M. Tapia Viñé; Madrid/ES - nothing to disclose D. Bernabéu Taboada; Madrid/ES - nothing to disclose

Hassouna H, Singh D. Morton’s metatarsalgia: pathogenesis, aetiology and current management. Acta Orthop Belg. 2005;71:646-655. Jain S, Mannan K, The diagnosis and management of Morton’s neuroma: a literature review. Foot Ankle Spec. 2313;6:307-17. Thomson CE, Gibson JN, Martin D. Interventions for the treatment of Morton’s neuroma. Cochrane Database Syst Rev. 2004. Valisena S, Petri GJ, Ferrero A. Treatment of Morton’s neuroma: a systematic review. Foot Ankle Surg. 2017. Matthews B, Hurn S, Harding M, Henry R, Ware R. The effectiveness of non-surgical interventions for common...